Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Beta in Chemotherapy-Induced Anemia
NCT00144495Phase 3Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Feb 2004
- Primary completion
- Nov 2004
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
A Phase 3 trial of epoetin beta in Chemotherapy-induced anemia (CIA), sponsored by Chugai Pharmaceutical Co., Ltd.. Started Feb 2004; status: completed.
02
Drugs
epoetin beta
03
Conditions
Chemotherapy-induced anemia (CIA)
Beyond the preview
Go deeper on NCT00144495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144495.